e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular surveillance of multi-drug resistant tuberculosis in Europe
I. Devaux, D. Falzon, K. Kremer, D. Van Sooligen (Saint Maurice, France; Bilthoven, Netherlands)
Source:
Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Session type:
Oral Presentation
Number:
1324
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Devaux, D. Falzon, K. Kremer, D. Van Sooligen (Saint Maurice, France; Bilthoven, Netherlands). Molecular surveillance of multi-drug resistant tuberculosis in Europe. Eur Respir J 2007; 30: Suppl. 51, 1324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Molecular epidemiology of M. tuberculosis drug resistance in Europe
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015
Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002
Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007
The WHO strategy for TB control and elimination
Source: Eur Respir Mon 2012; 58: 242-253
Year: 2012
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Mycobacterium tuberculosis
drug resistance surveillance in Belarus
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005
Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012
Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR)
mycobacterium tuberculosis
strains in clinical practice
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Multidrug resistance of
M. tuberculosis
and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Recent transmission of drug resistant
M. tuberculosis
in Latvia
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept